Art

J-GLOBAL ID：201402214787774115   Reference number：14A0618488

Second-line treatments for dyslipidemia in patients at risk of cardiovascular disease

心血管疾患の危険性がある患者における脂質異常症の二次治療

Author (14)： KONDO Yoshinobu (Dep. of Endocrinology and Metabolism, Chigasaki Municipal Hospital, Chigasaki, JPN) ,  KONDO Yoshinobu (Dep. of Endocrinology and Metabolism, Graduate School of Medicine, Yokohama City Univ., Yokohama, JPN) ,  HAMAI Junko (Dep. of Endocrinology and Metabolism, Graduate School of Medicine, Yokohama City Univ., Yokohama, JPN) ,  NEZU Uru (Dep. of Clinical Pharmacology and Therapeutics, Graduate School of Medicine, Univ. of the Ryukyus, Okinawa, JPN) ,  SHIGEMATSU Erina (Dep. of Endocrinology and Diabetes, Yokohama City Univ. Medical Center, Yokohama, JPN) ,  KAMIKO Kazunari (Dep. of Endocrinology and Diabetes, Saiseikai Yokohama-shi Nanbu Hospital, Yokohama, JPN) ,  YAMAZAKI Shunsuke (Dep. of Diabetes and Endocrinology, Fujisawa City Hospital, Fujisawa, JPN) ,  YOSHII Taishi (Div. of Metabolism and Endocrinology, Dep. of Internal Medicine, Yokohama Sakae Kyosai Hospital, Yokohama, JPN) ,  TAKAHASHI Mayumi (Dep. of Endocrinology and Diabetes, Saiseikai Yokohama-shi Nanbu Hospital, Yokohama, JPN) ,  TAKANO Tatsuro (Dep. of Diabetes and Endocrinology, Fujisawa City Hospital, Fujisawa, JPN) ,  KAWASAKI Satsuki (Dep. of Endocrinology and Metabolism, Shonan Fujisawa Tokushukai Hospital, Fujisawa, JPN) ,  YAMADA Masayo (Div. of Metabolism and Endocrinology, Dep. of Internal Medicine, Yokohama Sakae Kyosai Hospital, Yokohama, JPN) ,  YAMAKAWA Tadashi (Dep. of Endocrinology and Diabetes, Yokohama City Univ. Medical Center, Yokohama, JPN) ,  TERAUCHI Yasuo (Dep. of Endocrinology and Metabolism, Graduate School of Medicine, Yokohama City Univ., Yokohama, JPN)
Material： Endocrine Journal  (Endocr J)
Volume： 61  Issue： 4  Page： 343-351 (J-STAGE)  Publication year： 2014 
JST Material Number： F0625A  ISSN： 0918-8959  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *Second-line treatment ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0618488&from=J-GLOBAL&jstjournalNo=F0625A") }}

JST classification (1)： Treatment for metabolic diseases,nutritional diseases.  (GD05030F)

Substance index (2)： Ezetimibe ,  Cholesterol

Reference (32)：

• 1. Stamler J (1986) Is Relationship Between Serum Cholesterol and Risk of Premature Death From Coronary Heart Disease Continuous and Graded? JAMA 256: 2823.
• 2. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, et al. (2007) Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 370: 1829-1839.
• 3. Verschuren WM, Jacobs DR, Bloemberg BP, Kromhout D, Menotti A, et al. (1995) Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA 274: 131-136.
• 4. Imano H, Noda H, Kitamura A, Sato S, Kiyama M, et al. (2011) Low-density lipoprotein cholesterol and risk of coronary heart disease among Japanese men and women: the Circulatory Risk in Communities Study (CIRCS). Prev Med 52: 381-386.
• 5. Saito I, Folsom AR, Aono H, Ozawa H, Ikebe T, et al. (2000) Comparison of fatal coronary heart disease occurrence based on population surveys in Japan and the USA. Int J Epidemiol 29: 837-844.

Terms in the title (5)： 心血管疾患 ,  危険性 ,  患者 ,  脂質異常症 ,  二次治療